REPRODUCTIVE HEALTH IN TRANS AND GENDER DIVERSE PATIENTS: Fertility treatment and preservation options for transgender and gender diverse people

Elizabeth Rubin, Marissa Palmor, Paula Amato

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

In brief: Many transgender and gender diverse (TGD) people want to have biologically related children. This review summarizes and discusses the options for fertility treatment and preservation in TGD adults and adolescents, with an emphasis on gender-affirming hormone therapy in the context of fertility treatment, clinical management strategies to minimize gender dysphoria during treatment and major factors in future use of cryopreserved gametes. Abstract: Years of growing research demonstrate that TGD people desire fertility counseling and family building; however, social and medical factors can impact future fertility options. Fortunately, TGD individuals have many viable options for family building using their own gametes and/or reproductive organs. However, the nuanced ways in which different gender-affirming treatments affect reproduction, the interplay with nontreatment-related infertility factors and mitigation of likely dysphoria triggers are all critical to actual utilization. This review focuses on fertility treatment and preservation options for TGD patients and highlights these influential social and medical factors. Fertility treatments may be associated with worsening gender dysphoria in TGD people, and an affirming clinical environment and conscientious provider approach is paramount to treatment success. However, reducing gender dysphoria can also require specific changes to medically assisted reproduction and sperm collection protocols, some of which carry the potential for diminished outcomes or unknown effects. Adolescents undergoing fertility preservation treatments may need more support or additional protocol modifications, and outcomes may be poorer in this age group compared with adults. Testicular and ovarian tissue cryopreservation may present a fertility preservation option for prepubertal TGD children; however, in vitro gamete maturation remains experimental in this situation.

Original languageEnglish (US)
JournalReproduction
Volume169
Issue number1
DOIs
StatePublished - Jan 1 2025

Keywords

  • estradiol
  • fertility
  • gender affirmation
  • in vitro fertilization
  • testosterone
  • transgender

ASJC Scopus subject areas

  • Reproductive Medicine
  • Embryology
  • Endocrinology
  • Obstetrics and Gynecology
  • Cell Biology

Fingerprint

Dive into the research topics of 'REPRODUCTIVE HEALTH IN TRANS AND GENDER DIVERSE PATIENTS: Fertility treatment and preservation options for transgender and gender diverse people'. Together they form a unique fingerprint.

Cite this